Work

In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer

Year: 2006

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2006.09.011

Authors: Amy L. Cooper, Victoria L. Greenberg, Pamela S. Lancaster, John R. van Nagell, Stephen G. Zimmer, Susan C. Modesitt

Institutions: University of Kentucky, Albert B. Chandler Hospital, University of Virginia

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute on Drug Abuse

Awards: BUILDING INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S HEALTH IN KENTUCKY, G5534006824

OpenAlex ID: W1973666076

FWCI: 1.351

Cites: 55

Cited by: 59

Related to: 10